VIO-01

N/A

Report date: 2025/03/18 20:00:05
NME

Base Information

Drug NameVIO-01
Drug Alias NameVIO-01OX-425
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide
Mechanisms of ActionStimulator of interferon genes stimulantsPoly (ADP-Ribose) polymerase 1 modulators
TargetsStimulator of interferon genesPoly (ADP-Ribose) polymerase 1
Therapy Area/IndicationsSolid tumoursProstatic NeoplasmsOvarian Neoplasms +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusIND
Highest Status in ChinaN/A
Originator CompaniesValerio Therapeutics SA
China Registration ClassN/A

Develop Information

Active CompaniesValerio Therapeutics SA
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsSolid tumoursProstatic NeoplasmsOvarian Neoplasms +[4] 

Other Information

ATC CodeN/A
Related LinksN/A